Daewoong Pharmaceutical and CGBIO Launch Medical Device for Companion Animal Skin Barrier Care
Introducing Adhesive Transparent Wound Dressing for Animals
"Expanding Innovative Treatment Options for Companion Animals"
Daewoong Pharmaceutical is strengthening its position in the pet healthcare market by launching a new medical device for animals.
On July 1, Daewoong Pharmaceutical announced that 'BEARSOME,' an adhesive transparent wound dressing for animals co-developed with CGBIO, has received product approval from the Animal and Plant Quarantine Agency and has been officially launched in the domestic market.
Adhesive Transparent Wound Dressing for Animals 'BEARSOME'. Daewoong Pharmaceutical
View original imageBEARSOME is a veterinary medical device used to protect the skin areas of companion animals with damaged skin barriers due to first-degree burns, dryness, or wounds, and to prevent contamination. It forms a physical protective barrier by adhering closely to the injured area, preventing the wound from drying out and maintaining an optimal moisture environment. The stem cell culture medium contained in the product provides an advanced barrier care solution for damaged skin areas.
BEARSOME will be supplied to veterinary hospitals nationwide through the distribution network of Daewoong Pet, a company specializing in pet healthcare.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Seongsoo Park, CEO of Daewoong Pharmaceutical, stated, "BEARSOME is a product born from combining Daewoong Pharmaceutical's biotechnology capabilities with CGBIO's expertise in medical device development," adding, "We will continue to expand innovative treatment options to enhance the health and quality of life of companion animals in the future."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.